Previous close | 1.7000 |
Open | 1.6700 |
Bid | 0.0000 x 800 |
Ask | 0.0000 x 1000 |
Day's range | 1.5600 - 1.6799 |
52-week range | 1.3400 - 11.1000 |
Volume | |
Avg. volume | 70,500 |
Market cap | 20.734M |
Beta (5Y monthly) | 1.78 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
The next iteration of HOLO Portal delivers advancements based on early clinical experience and insights from leading spine surgeons in the U.S.DEERFIELD, Ill., March 20, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced the first major upgrade of the HOLO Portal™ Surgical Guidance System since the first case was performed in May of 2022. Since
DEERFIELD, Ill., March 16, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that it will be hosting its 2023 Annual Meeting of Shareholders virtually, on Thursday, June 1, 2023 at 9 a.m. PT. Shareholders will be able to access the Company’s Proxy Statement and Annual Report on Form 10-K once they are filed with the Securities and Exchange Comm
Surgalign’s HOLO AI Insights aims to enhance clinical decision making through the power of AI technologyDEERFIELD, Ill., March 13, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, is proud to announce the release of HOLO AI Insights. HOLO AI Insights enables customers, partners, and clinical researchers to take advantage of the Company’s HOLO artificial intel